AR Coactivators, Mechanisms & Roles in Prostate Cancer
AR Coactivators, Mechanisms & Roles in Prostate Cancer
批准号:
7057269
负责人:
SOPHIA Y. TSAI
金额:
$27.19万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2007-05-31
中文摘要
描述(由申请人提供):
在过去的几年里,在揭示AR在前列腺癌中的作用以及AR调节转录的机制方面取得了重大进展。首先,AR的转录功能是通过一系列不同的称为辅活化子的蛋白质来调节的,这一点已经很清楚。第二,AR除了在雄激素依赖型前列腺癌中起关键作用外,现在被认为在大多数雄激素非依赖性前列腺癌中功能活跃,实际上可能与雄激素非依赖型前列腺癌的发生和发展有关。然而,尽管有这一重大进展,不同的AR共激活子调节AR激活的机制仍然知之甚少。由于大多数AR共激活子都是通过瞬时转染法进行研究的,这些辅助因子调节AR活性的相关性和机制也应该在染色质的背景下进行分析。在这一应用中,我们建议以非洲爪哇卵母细胞为模型系统,研究SRC家族共激活因子、p300和RAN/ARA24在染色质背景下调节AR转录活性的分子机制。此外,由于大多数AR共激活子是通过酵母双杂交筛选来鉴定的,我们建议建立一种生化方法来研究和鉴定新的AR共激活子。最后,在我们的机制研究的基础上,我们建议产生显性的负共激活分子,可以用来抑制或阻断AR的转录功能。我们相信这些分子可能成为前列腺癌治疗的潜在治疗工具。
英文摘要
DESCRIPTION (provided by applicant):
Significant progress has been made over the last several years in unraveling the roles of AR in prostate cancer and the mechanisms by which AR regulates transcription. First, it has become clear that the transcriptional function of AR is mediated through a diverse array of proteins termed coactivators. Second, in addition to its pivotal roles in androgen-dependent prostate cancer, AR is now believed to be functionally active in most androgen-refractory prostate cancer and may actually contribute to the occurrence and progression of androgen-independent prostate cancer. Despite of [sic] this significant progress, however, the mechanisms by which diverse AR coactivators modulate AR activation are still poorly understood. As most of the AR coactivators have been studied by transient transfection assays, the relevance and the mechanisms by which these cofactors modulate AR activity should also be analyzed in the context of chromatin. In this application, we propose to investigate the molecular mechanisms by which SRC family coactivators, p300, and Ran/ARA24 modulate AR transcriptional activity in the context of chromatin by using Xenopus oocytes as a model system. In addition, as most of AR coactivators are identified by yeast two hybrid screenings, we propose to develop a biochemical approach to study and identify new AR coactivators. Finally, on the basis of our mechanistic studies, we propose to generate dominant negative coactivator molecules that can be used to inhibit or block the AR transcriptional function. We believe such molecules could be the potential therapeutic tools for prostate cancer therapy.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Nuclear Orphan Receptor, COUP-TFII, in Energy Metabolism and Disease
-
批准号:8701374
-
项目类别:
-
资助金额:$38.34万
-
财政年份:2013
-
负责人:SOPHIA Y. TSAI
-
依托单位:
Nuclear Orphan Receptor, COUP-TFII, in Energy Metabolism and Disease
-
批准号:8495646
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2013
-
负责人:SOPHIA Y. TSAI
-
依托单位:
ORPHAN RECEPTOR COUP-TFII IN ADIPOCYTE DIFFERENTIATION
-
批准号:7477174
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2007
-
负责人:SOPHIA Y. TSAI
-
依托单位:
ORPHAN RECEPTOR COUP-TFII IN ADIPOCYTE DIFFERENTIATION
-
批准号:7215497
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2006
-
负责人:SOPHIA Y. TSAI
-
依托单位:
A Nuclear Receptor COUP-TFII in Vascular Function: Angiogenesis and Tumoirgenesis
-
批准号:8299127
-
项目类别:
-
资助金额:$37.99万
-
财政年份:2004
-
负责人:SOPHIA Y. TSAI
-
依托单位:
A Nuclear Receptor COUP-TFII in Cardiovascular Function
-
批准号:7323276
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2004
-
负责人:SOPHIA Y. TSAI
-
依托单位:
A Nuclear Receptor COUP-TFII in Vascular Function: Angiogenesis and Tumoirgenesis
-
批准号:7701397
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2004
-
负责人:SOPHIA Y. TSAI
-
依托单位:
A Nuclear Receptor COUP-TFII in Cardiovascular Function
-
批准号:6992737
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2004
-
负责人:SOPHIA Y. TSAI
-
依托单位:
A Nuclear Receptor COUP-TFII in Cardiovascular Function
-
批准号:7148073
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2004
-
负责人:SOPHIA Y. TSAI
-
依托单位:
A Nuclear Receptor COUP-TFII in Vascular Function: Angiogenesis and Tumoirgenesis
-
批准号:7891212
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2004
-
负责人:SOPHIA Y. TSAI
-
依托单位:
A Nuclear Receptor COUP-TFII in Cardiovascular Function
-
批准号:6874051
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2004
-
负责人:SOPHIA Y. TSAI
-
依托单位:
Nuclear orphan receptor COUP-TFII in postate development
-
批准号:6589551
-
项目类别:
-
资助金额:$17.72万
-
财政年份:2002
-
负责人:SOPHIA Y. TSAI
-
依托单位:
REGULATABLE GENE TRANSFER SYSTEM
-
批准号:6501124
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2001
-
负责人:SOPHIA Y. TSAI
-
依托单位:
Nuclear orphan receptor COUP-TFII in postate development
-
批准号:6452767
-
项目类别:
-
资助金额:$17.72万
-
财政年份:2001
-
负责人:SOPHIA Y. TSAI
-
依托单位:
Functional Interactions of SRC-2 and COUP-TFII in Muscle Energy Metabolism
-
批准号:8856212
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2001
-
负责人:SOPHIA Y. TSAI
-
依托单位:
REGULATABLE GENE TRANSFER SYSTEM
-
批准号:6565065
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2001
-
负责人:SOPHIA Y. TSAI
-
依托单位:
Functional Interactions of SRC-2 and COUP-TFII in Muscle Energy Metabolism
-
批准号:8703670
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2001
-
负责人:SOPHIA Y. TSAI
-
依托单位:
Functional Interactions of SRC-2 and COUP-TFII in Muscle Energy Metabolism
-
批准号:8545166
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2001
-
负责人:SOPHIA Y. TSAI
-
依托单位:
Functional Interactions of SRC-2 and COUP-TFII in Muscle Energy Metabolism
-
批准号:8419651
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2001
-
负责人:SOPHIA Y. TSAI
-
依托单位:
REGULATABLE SYSTEM FOR AMELIORATION OF NEURAL DYSFUNCTION
-
批准号:6318258
-
项目类别:
-
资助金额:$7.96万
-
财政年份:2000
-
负责人:SOPHIA Y. TSAI
-
依托单位:
海外基金